FGF19 upregulates ELF4 expression via the ERK1/2-SP1 axis, which subsequently activates downstream targets like SRC and FGFR4 itself, creating a positive feedback loop that amplifies the metastatic potential of CRC cells [198]. This evidence concerns the gene FGF19 and colorectal carcinoma.